Solventum Corporation (SOLV)

From the record

Solventum Corporation's filings since 2023 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Solventum Corporation's 4 filed years say what it did: revenue went from $8.1 billion in fiscal 2022 to $8.3 billion in fiscal 2025, up 0.8% a year; it rose in 3 of 3 years; it never fell from a peak; net income was positive in 4 of 4 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Solventum Corporation's diluted share count grew about 0.5% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 1 purchase of their own stock on the open market in the year to 2026-09-30, buying about $100 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Solventum Corporation earned about 31 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 31 cents per dollar of everything the company owns. Leverage: it owed about 65 cents per dollar of assets, and net share issuance: its share count grew 0.9% over the year (the filed statements).

From the record

Solventum Corporation's standing among 109 graded names in its industry family: revenue of $8.3 billion in fiscal 2025 ranks in the top 6% by size; a net margin of 18.7% ranks in the top 7%; revenue growth of 0.8% a year over the last 3 filed years ranks in the bottom 24% (its annual reports).

From the record

Solventum Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $878 million against debt of $5.0 billion leaves -29.1% of its assets as net cash, bottom 8% of its family; cash from operations less capital spending is -0.1% of revenue (top 42%); a gross margin of 53.5% (bottom 34%); research spending of 8.9% of revenue (bottom 39%) (its annual report).

From the record

Solventum Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 0.8% a year over the last three filed years against 0.8% over all 4, speeding up (top 43% of its family); the newest year grew 0.9% (bottom 22%); research spending grew -1.2% a year (bottom 30%); capital spending grew 14.7% a year (top 30%) (its annual reports). Solventum Corporation reported 2 product lines in fiscal 2025: Product at $6.3 billion (76%), Cost of Software and Rentals at $2.0 billion (24%); 2 of 2 grew against the year before (its annual report).

From the record

Solventum Corporation's newest year against its own record: revenue of $8.3 billion in fiscal 2025 came in 0.1% above the $8.3 billion its prior three years' pace pointed to (top 38% of its family); net income of $1.6 billion against a prior three-year average of $1.1 billion (top 36%); a net margin of 18.7% against 12.9% before (bottom 43%) (its annual reports).